You just read:

Aridis Pharmaceuticals Enrolls Its First COVID-19 Patient in Ongoing Phase 3 AR-301 Clinical Trial in Ventilator Associated Pneumonia (VAP)

News provided by

Aridis Pharmaceuticals, Inc.

May 04, 2020, 05:30 ET